Methylation events themselves also may be linked and interact with each other, presenting a challenge to define an optimal panel of methylation markers as well. A CpG island methylator phenotype, consisting of distinct subtypes of GC with co-ordinated methylation patterns, has been described, although the evidence for CIMP in GC is not as convincing as for colorectal cancer. In conclusion, the results of this study summarize a promising value for DNA methylation to the risk prediction, prognostication and prediction of response to chemotherapy of GC. However, significant methodological and validation issues remain to be addressed to provide the data that will enable this information to be considered for the clinic. This includes the analysis of larger independent sample series, application of standardized methods, adjustment for co-variates in multivariate analysis, greater definition of outcome endpoints and adjustment for the effect of treatment intervention. The realization of the potential of DNA methylation to GC clinical management awaits their resolution. The excitatory neurotransmitter glutamate is not degraded in the extracellular space following release. Rather, clearance of glutamate release into the synaptic cleft depends on diffusion and uptake to terminate synaptic transmission and prevent excitotoxicity. Despite the efficiency and high expression density of glutamate transporters, a measurable concentration of glutamate exists in the extracellular space of neuronal tissue. Estimates of this ambient concentration range from tens of nanomolar to tens of micromolar depending on the measurement technique used; electrophysiological methods yield lower estimates than microdialysis or amperometry. We estimated in a previous study that extracellular glutamate in acute hippocampal slices is,25 nM, a concentration that produces a small but detectable tonic current in CA1 pyramidal neurons that is mediated by N-methyl-D-aspartic acid receptors. This current represents the activity of all NMDARs expressed by the neuron and does not differentiate between synaptic and Octinoxate extrasynaptic receptors. Due to the complex architecture of the neuropil and the heterogeneous distribution of glutamate transporters, it has been suggested that ambient glutamate concentrations are much Citiolone higher in the extrasynaptic space than in the synaptic cleft giving rise to preferential activation of extrasynaptic NMDARs. As synaptic NMDARs greatly outnumber extrasynaptic NMDARs, the 25 nM concentration estimate yielded by our previous approach may mainly reflect the concentration within the cleft, thus dramatically underestimating the glutamate concentration in the extrasynaptic space. In this scenario, the higher estimates of ambient glutamate obtained with microdialysis and amperometry would reflect measurements of the extrasynaptic space. To determine the location of NMDARs activated by ambient glutamate, a technique with spatial resolution is required.